BMJ Evidence-Based Medicine最新文献

筛选
英文 中文
Enhancing clinical practice guidelines with STAR. 利用 STAR 加强临床实践指南。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-10-09 DOI: 10.1136/bmjebm-2024-112893
Nan Yang, Hui Liu, Janne Estill, Yaolong Chen
{"title":"Enhancing clinical practice guidelines with STAR.","authors":"Nan Yang, Hui Liu, Janne Estill, Yaolong Chen","doi":"10.1136/bmjebm-2024-112893","DOIUrl":"https://doi.org/10.1136/bmjebm-2024-112893","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meet generative AI… your new shared decision-making assistant. 认识一下生成式人工智能......您新的共同决策助手。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2023-112651
Glyn Elwyn, Padhraig Ryan, Daniel Blumkin, William B Weeks
{"title":"Meet generative AI… your new shared decision-making assistant.","authors":"Glyn Elwyn, Padhraig Ryan, Daniel Blumkin, William B Weeks","doi":"10.1136/bmjebm-2023-112651","DOIUrl":"10.1136/bmjebm-2023-112651","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"292-295"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141309953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review. 减少医疗保健产生的温室气体排放的临床医生和医疗服务干预措施:系统综述。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2023-112707
Kristen Pickles, Romi Haas, Michelle Guppy, Denise A O'Connor, Thanya Pathirana, Alexandra Barratt, Rachelle Buchbinder
{"title":"Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review.","authors":"Kristen Pickles, Romi Haas, Michelle Guppy, Denise A O'Connor, Thanya Pathirana, Alexandra Barratt, Rachelle Buchbinder","doi":"10.1136/bmjebm-2023-112707","DOIUrl":"10.1136/bmjebm-2023-112707","url":null,"abstract":"<p><strong>Objective: </strong>To synthesise the available evidence on the effects of interventions designed to improve the delivery of healthcare that reduces the greenhouse gas (GHG) emissions of healthcare.</p><p><strong>Design: </strong>Systematic review and structured synthesis.</p><p><strong>Search sources: </strong>Cochrane Central Register of Controlled Trials, PubMed, Web of Science and Embase from inception to 3 May 2023.</p><p><strong>Selection criteria: </strong>Randomised, quasi-randomised and non-randomised controlled trials, interrupted time series and controlled or uncontrolled before-after studies that assessed interventions primarily designed to improve the delivery of healthcare that reduces the GHG emissions of healthcare initiated by clinicians or healthcare services within any setting.</p><p><strong>Main outcome measures: </strong>Primary outcome was GHG emissions. Secondary outcomes were financial costs, effectiveness, harms, patient-relevant outcomes, engagement and acceptability.</p><p><strong>Data collection and analysis: </strong>Paired authors independently selected studies for inclusion, extracted data, and assessed risk of bias using a modified checklist for observational studies and the certainty of the evidence using Grades of Recommendation, Assessment, Development and Evaluation. Data could not be pooled because of clinical and methodological heterogeneity, so we synthesised results in a structured summary of intervention effects with vote counting based on direction of effect.</p><p><strong>Results: </strong>21 observational studies were included. Interventions targeted delivery of anaesthesia (12 of 21), waste/recycling (5 of 21), unnecessary test requests (3 of 21) and energy (1 of 21). The primary intervention type was clinician education. Most (20 of 21) studies were judged at unclear or high risk of bias for at least one criterion. Most studies reported effect estimates favouring the intervention (GHG emissions 17 of 18, costs 13 of 15, effectiveness 18 of 20, harms 1 of 1 and staff acceptability 1 of 1 studies), but the evidence is very uncertain for all outcomes (downgraded predominantly for observational study design and risk of bias). No studies reported patient-relevant outcomes other than death or engagement with the intervention.</p><p><strong>Conclusions: </strong>Interventions designed to improve the delivery of healthcare that reduces GHG emissions may reduce GHG emissions and costs, reduce anaesthesia use, waste and unnecessary testing, be acceptable to staff and have little to no effect on energy use or unintended harms, but the evidence is very uncertain. Rigorous studies that measure GHG emissions using gold-standard life cycle assessment are needed as well as studies in more diverse areas of healthcare. It is also important that future interventions to reduce GHG emissions evaluate the effect on beneficial and harmful patient outcomes.</p><p><strong>Prospero registration number: </strong>CRD4","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"300-312"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ambiguity in care delivery terminology: implications that affect pragmatic clinical trials using non-pharmacological interventions. 护理交付术语的歧义:影响使用非药物干预的实用临床试验的含义。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2023-112547
Daniel I Rhon, Alison F Davis, Joseph Ali, Cynthia Brandt, Amy Burns, Whitley Lucio, Robert Vining, Stacey Young-McCaughan
{"title":"Ambiguity in care delivery terminology: implications that affect pragmatic clinical trials using non-pharmacological interventions.","authors":"Daniel I Rhon, Alison F Davis, Joseph Ali, Cynthia Brandt, Amy Burns, Whitley Lucio, Robert Vining, Stacey Young-McCaughan","doi":"10.1136/bmjebm-2023-112547","DOIUrl":"10.1136/bmjebm-2023-112547","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"296-299"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138290245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can a replication revolution resolve the duplication crisis in systematic reviews? 复制革命能否解决系统审查中的复制危机?
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2022-112125
Sathya Karunananthan, Jeremy M Grimshaw, Lara Maxwell, Phi-Yen Nguyen, Matthew J Page, Jordi Pardo Pardo, Jennifer Petkovic, Brigitte Vachon, Vivian Andrea Welch, Peter Tugwell
{"title":"Can a replication revolution resolve the duplication crisis in systematic reviews?","authors":"Sathya Karunananthan, Jeremy M Grimshaw, Lara Maxwell, Phi-Yen Nguyen, Matthew J Page, Jordi Pardo Pardo, Jennifer Petkovic, Brigitte Vachon, Vivian Andrea Welch, Peter Tugwell","doi":"10.1136/bmjebm-2022-112125","DOIUrl":"10.1136/bmjebm-2022-112125","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"285-288"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41190865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shared decision-making and evidence-based medicine series: exploring contemporary challenges and future directions. 共同决策与循证医学系列:探讨当代挑战与未来方向。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2024-113024
Paula Riganti, Tammy C Hoffmann
{"title":"Shared decision-making and evidence-based medicine series: exploring contemporary challenges and future directions.","authors":"Paula Riganti, Tammy C Hoffmann","doi":"10.1136/bmjebm-2024-113024","DOIUrl":"10.1136/bmjebm-2024-113024","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"283-284"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications. 临床试验设计与治疗效果:对支持 437 项 FDA 批准的癌症药物和适应症的随机对照试验和单臂试验进行的荟萃分析。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2023-112544
Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Julia Caroline Michaeli
{"title":"Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications.","authors":"Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Julia Caroline Michaeli","doi":"10.1136/bmjebm-2023-112544","DOIUrl":"10.1136/bmjebm-2023-112544","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to analyse the association between clinical trial design and treatment effects for cancer drugs with US Food and Drug Administration (FDA) approval.</p><p><strong>Design: </strong>Cross-sectional study and meta-analysis.</p><p><strong>Setting: </strong>Data from Drugs@FDA, FDA labels, ClincialTrials.gov and the Global Burden of Disease study.</p><p><strong>Participants: </strong>Pivotal trials for 170 drugs with FDA approval across 437 cancer indications between 2000 and 2022.</p><p><strong>Main outcome measures: </strong>Treatment effects were measured in HRs for overall survival (OS) and progression-free survival (PFS), and in relative risk for tumour response. Random-effects meta-analyses and meta-regressions explored the association between treatment effect estimates and clinical trial design for randomised controlled trials (RCTs) and single-arm trials.</p><p><strong>Results: </strong>Across RCTs, greater effect estimates were observed in smaller trials for OS (ß=0.06, p<0.001), PFS (ß=0.15, p<0.001) and tumour response (ß=-3.61, p<0.001). Effect estimates were larger in shorter trials for OS (ß=0.08, p<0.001) and PFS (ß=0.09, p=0.002). OS (ß=0.04, p=0.006), PFS (ß=0.10, p<0.001) and tumour response (ß=-2.91, p=0.004) outcomes were greater in trials with fewer centres. HRs for PFS (0.54 vs 0.62, p=0.011) were lower in trials testing the new drug to an inactive (placebo/no treatment) rather than an active comparator. The analysed efficacy population (intention-to-treat, per-protocol, or as-treated) was not consistently associated with treatment effects. Results were consistent for single-arm trials and in multivariable analyses.</p><p><strong>Conclusions: </strong>Pivotal trial design is significantly associated with measured treatment effects. Particularly small, short, single-centre trials testing a new drug compared with an inactive rather than an active comparator could overstate treatment outcomes. Future studies should verify results in unsuccessful trials, adjust for further confounders and examine other therapeutic areas. The FDA, manufacturers and trialists must strive to conduct robust clinical trials with a low risk of bias.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"333-341"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140955606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in shared decision-making: the East-West divide. 共同决策的差异:东西方的分歧。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2023-112451
Weihua Chen, Huangruowen Zhang, Mingyue Xu, Rongchong Huang
{"title":"Differences in shared decision-making: the East-West divide.","authors":"Weihua Chen, Huangruowen Zhang, Mingyue Xu, Rongchong Huang","doi":"10.1136/bmjebm-2023-112451","DOIUrl":"10.1136/bmjebm-2023-112451","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"289-291"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71520381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vibration of effects resulting from treatment selection in mixed-treatment comparisons: a multiverse analysis on network meta-analyses of antidepressants in major depressive disorder. 混合治疗比较中治疗选择导致的效应振动:重度抑郁症抗抑郁药网络荟萃分析的多元宇宙分析。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2024-112848
Constant Vinatier, Clement Palpacuer, Alexandre Scanff, Florian Naudet
{"title":"Vibration of effects resulting from treatment selection in mixed-treatment comparisons: a multiverse analysis on network meta-analyses of antidepressants in major depressive disorder.","authors":"Constant Vinatier, Clement Palpacuer, Alexandre Scanff, Florian Naudet","doi":"10.1136/bmjebm-2024-112848","DOIUrl":"10.1136/bmjebm-2024-112848","url":null,"abstract":"<p><strong>Objective: </strong>It is frequent to find overlapping network meta-analyses (NMAs) on the same topic with differences in terms of both treatments included and effect estimates. We aimed to evaluate the impact on effect estimates of selecting different treatment combinations (ie, network geometries) for inclusion in NMAs.</p><p><strong>Design: </strong>Multiverse analysis, covering all possible NMAs on different combinations of treatments.</p><p><strong>Setting: </strong>Data from a previously published NMA exploring the comparative effectiveness of 22 treatments (21 antidepressants and a placebo) for the treatment of acute major depressive disorder.</p><p><strong>Participants: </strong>Cipriani <i>et al</i> explored a dataset of 116 477 patients included in 522 randomised controlled trials.</p><p><strong>Main outcome measures: </strong>For each possible treatment selection, we performed an NMA to estimate comparative effectiveness on treatment response and treatment discontinuation for the treatments included (231 between-treatment comparisons). The distribution of effect estimates of between-treatment comparisons across NMAs was computed, and the direction, magnitude and statistical significance of the 1st and 99th percentiles were compared.</p><p><strong>Results: </strong>4 116 254 different NMAs concerned treatment response. Among possible network geometries, 172/231 (74%) pairwise comparisons exhibited opposite effects between the 1st and 99th percentiles, 57/231 (25%) comparisons exhibited statistically significant results in opposite directions, 118 of 231 (51%) comparisons derived results that were both significant and non-significant at 5% risk and 56/231 (24%) treatment pairs obtained consistent results with only significant differences (or only non-significant differences) at 5% risk. Comparisons based on indirect evidence only were associated with greater variability in effect estimates. Comparisons with small absolute values observed in the complete NMA more frequently obtained statistically significant results in opposite directions. Similar results were observed for treatment discontinuation.</p><p><strong>Conclusion: </strong>In this multiverse analysis, we observed that the selection of treatments to be included in an NMA could have considerable consequences on treatment effect estimations.</p><p><strong>Trial registration: </strong>https://osf.io/mb5dy.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"324-332"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Four overlooked errors in ROC analysis: how to prevent and avoid. ROC 分析中被忽视的四个错误:如何预防和避免。
IF 9 3区 医学
BMJ Evidence-Based Medicine Pub Date : 2024-09-19 DOI: 10.1136/bmjebm-2024-113078
Zhuoqiao He, Qingying Zhang, Manshu Song, Xuerui Tan, Wei Wang
{"title":"Four overlooked errors in ROC analysis: how to prevent and avoid.","authors":"Zhuoqiao He, Qingying Zhang, Manshu Song, Xuerui Tan, Wei Wang","doi":"10.1136/bmjebm-2024-113078","DOIUrl":"https://doi.org/10.1136/bmjebm-2024-113078","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信